bone diseases Flashcards
the bone is
Mineralised Connective tissue
Load bearing
Dynamic
Self Repairing
Calcium
Phosphate
Vitamin D
parathyroid hormone
Maintains serum calcium level
RAISED if calcium levels fall
Increases calcium release from BONE
Reduces RENAL calcium excretion
Hypoparathyroidism = Low serum calcium
Hyperparathyoidism
Primary
Gland dysfunction – tumour
High serum calcium RESULTS
Secondary
low serum calcium CAUSES
Both result in increased bone reabsorption
Radiolucencies & reabsorption
vitamin d problems
Low Sunlight Exposure
Poor GI Absorption
Poor nutrition
Small intestinal disease - malabsorption
Drug interactions
Some antiepileptic drugs
Carbamazepine, Phenytoin
Often a combination of factors
osteomalacia is
During bone formation = “RICKETS”
After Bone formation completed = “Osteomalacia”
Both related to CALCIUM DEFICIENCY
Serum calcium preserved at expense of bone
osteomalacia effects
Bone Effects
Bones bend under pressure
‘bow legs’
Vertebral compression in adults
Bones ‘ache’ to touch
Hypocalcaemia effects
Muscle weakness
Trousseau & Chvostek signs positive
Carpal muscle spasm
Facial twitching from VII tapping
management of osteomalacia
Correct the cause
Malnutrition
Control GI disease
Sunlight exposure = 30 mins x 5 weekly
Dietary Vitamin D
what is osteoporosis
A REDUCED QUANTITY of normally mineralized Bone
An age related change
Inevitable
osteoporosis risk factors
AGE
Female sex = oestrogen withdrawal increases bone mass loss rate in women
Endocrine
Oestrogen & testosterone deficiency
Cushings syndrome
Genetic
Family history
Race – caucasian & asian women
Early menopause
Patient factors
Inactivity
Smoking
Excess alcohol use
Poor dietary calcium
Medical Drugs use
steroids
antiepileptics
osteoporosis prevention
Build maximal Peak Bone Mass
Exercise
High dietary calcium intake
Reduce rate of Bone Mass loss
Continue exercise and calcium intake
Reduce hormone related effects
Oestrogen Hormone replacement therapy
MOST effective if early menopause
hormone replacement therapy
Oestrogen only
Reduces osteoporosis risk
Increases breast cancer risk
Increase endometrial cancer risk
Patients who have NOT had a hysterectory
Combine with a progestogen to reduce risk
May reduce ovarian cancer risk
Increases DVT risk
Benefit lost after HRT stops!
5yrs post treatment BMD ‘normal’
bisphosphonates
Non-Nitrogenous
Etidronate (1)
Clodronate (10)
Tildronate (10)
Nitrogenous
Pamidronate (100)
Neridronate (100)
Olpadronate (500)
Alendronate (500)
Ibandronate (1000)
Risedronate (2000)
Zoledronate (10000)
Alendronate or Risedronate in an osteoporosis risk population
Reduce vertebral fracture risk by 50%
Reduce other fractures by 30-50%
benefit lost if drug discontinued
Can be combined with HRT